MALLEO, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 15.755
NA - Nord America 15.046
AS - Asia 10.981
SA - Sud America 1.669
AF - Africa 390
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 43.889
Nazione #
US - Stati Uniti d'America 14.681
RU - Federazione Russa 6.169
SG - Singapore 4.393
CN - Cina 3.173
GB - Regno Unito 2.598
IT - Italia 2.216
BR - Brasile 1.315
VN - Vietnam 994
HK - Hong Kong 978
DE - Germania 949
FR - Francia 908
IE - Irlanda 761
SE - Svezia 755
FI - Finlandia 433
KR - Corea 324
IN - India 221
NL - Olanda 205
CA - Canada 185
JP - Giappone 175
UA - Ucraina 154
MX - Messico 132
AR - Argentina 129
ES - Italia 116
TR - Turchia 101
BD - Bangladesh 96
NG - Nigeria 92
PL - Polonia 90
ID - Indonesia 88
IQ - Iraq 80
ZA - Sudafrica 71
AT - Austria 70
BE - Belgio 56
PK - Pakistan 56
EC - Ecuador 45
CZ - Repubblica Ceca 43
VE - Venezuela 38
CO - Colombia 37
TG - Togo 37
MA - Marocco 35
AU - Australia 33
LT - Lituania 33
BJ - Benin 31
CL - Cile 30
PH - Filippine 29
PY - Paraguay 29
TN - Tunisia 29
UZ - Uzbekistan 29
CH - Svizzera 27
EG - Egitto 25
AE - Emirati Arabi Uniti 24
JO - Giordania 24
NP - Nepal 23
PE - Perù 23
SA - Arabia Saudita 23
RO - Romania 21
KE - Kenya 20
DZ - Algeria 18
AZ - Azerbaigian 17
GR - Grecia 17
IL - Israele 15
MY - Malesia 15
LV - Lettonia 14
HU - Ungheria 13
KG - Kirghizistan 12
TH - Thailandia 12
AL - Albania 11
NO - Norvegia 11
PT - Portogallo 11
DK - Danimarca 10
IR - Iran 10
KZ - Kazakistan 10
SI - Slovenia 10
CR - Costa Rica 9
HR - Croazia 9
RS - Serbia 9
UY - Uruguay 9
BG - Bulgaria 8
BO - Bolivia 8
ET - Etiopia 8
PS - Palestinian Territory 8
DO - Repubblica Dominicana 7
JM - Giamaica 7
OM - Oman 7
LB - Libano 6
NZ - Nuova Zelanda 6
BA - Bosnia-Erzegovina 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
BB - Barbados 4
BH - Bahrain 4
EE - Estonia 4
GA - Gabon 4
LA - Repubblica Popolare Democratica del Laos 4
LU - Lussemburgo 4
PR - Porto Rico 4
SY - Repubblica araba siriana 4
UG - Uganda 4
AM - Armenia 3
BY - Bielorussia 3
EU - Europa 3
Totale 43.819
Città #
Singapore 2.291
Moscow 2.174
Southend 2.152
Ashburn 1.927
Dallas 1.789
Chandler 1.498
San Jose 1.457
Hong Kong 957
Verona 805
Dublin 736
Beijing 569
The Dalles 509
Jacksonville 507
Woodbridge 493
New York 373
Houston 366
Ho Chi Minh City 344
Ann Arbor 306
Munich 293
Los Angeles 292
Lawrence 243
Princeton 243
Hanoi 215
Jinan 215
Wilmington 215
Council Bluffs 181
Nanjing 178
Helsinki 175
Shenyang 157
São Paulo 155
Boardman 142
Tokyo 142
Redondo Beach 141
Orem 134
Santa Clara 130
Buffalo 124
Hebei 118
Redmond 111
Milan 107
Columbus 96
Sindelfingen 96
Tianjin 94
Turku 94
London 93
Abuja 83
Seattle 82
Frankfurt am Main 81
Haikou 79
Montreal 75
Hangzhou 72
Chennai 71
Zhengzhou 69
Ningbo 68
Warsaw 68
Changsha 67
Amsterdam 65
Rome 64
Denver 62
Stockholm 61
San Francisco 60
Atlanta 58
Guangzhou 56
Fairfield 54
Phoenix 54
Brooklyn 53
Chicago 53
Nanchang 53
Poplar 53
Bologna 52
Brussels 52
Da Nang 50
Taizhou 49
Toronto 49
Falkenstein 48
Mexico City 48
Redwood City 48
Johannesburg 47
Lancaster 47
Seoul 47
Haiphong 45
Rio de Janeiro 45
Taiyuan 45
Jiaxing 44
Nuremberg 42
Baghdad 37
Lomé 37
Mumbai 37
Paris 37
Vienna 37
Washington 37
Belo Horizonte 36
Lappeenranta 34
Jakarta 33
Manchester 33
Cotonou 31
Istanbul 28
Brasília 26
Fuzhou 26
Kent 26
Meda 26
Totale 26.277
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 873
STUDIO PROSPETTICO MULTICENTRICO SULLA GESTIONE DEI DRENAGGI DOPO DUODENOCEFALOPANCREASECTOMIA UTILIZZANDO UN SISTEMA DI STRATIFICAZIONE DEL RISCHIO 695
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial 392
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 282
Genomic characterization of hepatoid tumors: context matters 260
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia 249
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 246
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 237
Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic cystic lesions 235
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 233
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 232
Gα15 in early onset of pancreatic ductal adenocarcinoma 232
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 230
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 223
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? 222
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 221
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 217
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 217
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 216
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 215
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 215
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 212
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 208
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 208
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts 205
Characterization of adrenal lesions using MDCT wash-out parameters: diagnostic accuracy of several combinations of intermediate and delayed phases 205
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 204
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 204
Delaying surgery for patients with a previous SARS-CoV-2 infection 202
Acute pancreatitis at the beginning of the 21st century: the state of the art. 200
Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy 199
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 199
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 197
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study 196
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 194
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 192
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 192
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment 191
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 190
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 188
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 188
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections 186
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 185
Results of a surveillance protocol for pancreatic BD-IPMNs 185
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 184
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 184
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 184
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 183
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 183
Efficacy of Endoscopic Minor Papilla Sphincterotomy for Symptomatic Santorinicele Endoscopic treatment of Santorinicele 183
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 183
Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes 182
Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma 182
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 181
An unforeseeable adverse event during ERCP 179
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 179
Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma. 177
Dental plaque microbiota sequence counts for microbial profiling and resistance genes detection 176
Serous Cystic Neoplasms 176
Imaging after pancreatic surgery: normal post-operative findings, early and late complications with emphasis on CT imaging 175
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 175
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 175
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 175
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 175
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 174
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 173
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 173
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases 173
Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data 173
Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk Stratification 171
Branch Duct Intraductal Papillary Mucinous Neoplasms: Recommendations for Follow-Up and Surgery 171
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 171
Pancreaticojejunostomy after pancreaticoduodenectomy: Suture material and incidence of post-operative pancreatic fistula 171
Immune performance profile in pancreatic adenocarcinoma patients. 169
Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome 169
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 168
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma 168
Non-inferiority of open passive drains compared with closed suction drains in pancreatic surgery outcomes: A prospective observational study 168
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 168
Cystic Neoplasm of the Pancreas 166
Sex differences in oncogenic mutational processes 166
The management of intraductal papillary mucinous neoplasms of the pancreas 165
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis 164
The Actual Prevalence of Symptoms in Pancreatic Cystic Neoplasms: A Prospective Propensity Matched Cohort Analysis 163
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study 163
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 162
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center 162
Dislocation of intra-abdominal drains after pancreatic surgery: results of a prospective observational study 162
Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons 161
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma 161
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 160
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 160
Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or~Tail on Surgical and Oncological Outcome: A Propensity-Score~Matched Multicenter Study 160
A Surface Plasmon Resonance Plastic Optical Fiber Biosensor for the Detection of Pancreatic Amylase in Surgically-Placed Drain Effluent 159
CT Simplified Radiomic Approach to Assess the Metastatic Ductal Adenocarcinoma of the Pancreas 159
ASO Visual Abstract: Prognostic Factors After Pancreatectomy for Pancreatic Cancer Initially Metastatic to the Liver 158
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 158
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer 157
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 157
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 156
Totale 20.202
Categoria #
all - tutte 144.842
article - articoli 136.225
book - libri 0
conference - conferenze 2.331
curatela - curatele 0
other - altro 2.156
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.130
Totale 289.684


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021323 0 0 0 0 0 0 0 0 0 48 171 104
2021/20221.828 184 448 51 139 59 34 33 127 98 51 139 465
2022/20234.811 291 521 401 765 398 1.324 114 307 473 53 97 67
2023/20242.660 88 217 261 277 281 417 169 221 47 102 429 151
2024/20256.738 356 335 248 1.027 359 203 420 345 996 497 664 1.288
2025/202621.172 1.417 1.390 1.636 3.575 5.367 1.410 1.880 1.330 1.927 1.240 0 0
Totale 44.379